Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis.

Fei Cheng,Chunyan Zeng,Ling Zeng,Youxiang Chen
DOI: https://doi.org/10.1097/MD.0000000000017310
IF: 1.6
2019-01-01
Medicine
Abstract:Background: Increasing evidence has revealed that plasma fibrinogen may serve as a prognostic indicator in multiple malignancies. However, there have been some conflicting findings on the prognostic value of plasma fibrinogen in gastric cancer (GC). We conducted a meta-analysis to explore the correlation between plasma fibrinogen and clinic outcome in GC. Methods: A comprehensive literature search was conducted using the Embase, the Web of Science, the Cochrane library, and PubMed databases. Combined hazard ratios (HRs) and odds ratios (ORs) with 95% confidence intervals (CIs) were used to investigate the impact of elevated plasma fibrinogen on the prognosis and clinicopathological features of patients with GC. Results: A total of 11 studies involving 8315 patients were selected for this meta-analysis. The pooled results suggested that elevated plasma fibrinogen in GC patients was related to worse overall survival (OS) (HR= 1.57, 95% CI: 1.36-1.81, P<.001) and recurrence-free survival (RFS) (HR= 2.54; 95% CI: 1.19-5.41, P=.016). Additionally, a high level of fibrinogen was closely correlated with advanced tumor stage (OR= 2.14, 95% CI: 1.83-2.50, P<.001), lymph node metastasis (OR= 1.81, 95% CI: 1.56-2.11, P<.001), distant metastasis (OR= 1.48, 95% CI: 1.12-1.94, P=.005), deeper tumor invasion (OR= 2.25, 95% CI: 1.47-3.45, P<.001) and high carcinoembryonic antigen (OR= 1.41, 95% CI: 1.18-1.68, P<.001). However, there was no significant association between plasma fibrinogen and the differentiation grade (OR= 1.00, 95% CI: 0.86-1.17, P=.967). The Egger regression test indicated evidence of publication bias for OS. Conclusion: Elevated plasma fibrinogen could be a potential predictor for worse OS and RFS in GC patients and a significant risk factor associated with aggressive clinical features.
What problem does this paper attempt to address?